Table 4.
Pathologic traits | Gene signature | OR | 95% CI | P |
---|---|---|---|---|
Size >5 cm | Boyault_G3 [25] | 3.93 | 1.03–15.00 | 0.045 |
Lee_Poor survival [49] | 4.86 | 1.21–19.47 | 0.026 | |
Chiang_Proliferation [22] | 5.06 | 1.20–21.42 | 0.028 | |
Villanueva_KRT19 [6] | 6.43 | 1.51–27.45 | 0.012 | |
Andersen_KRT19 [27] | 8.25 | 1.90–35.91 | 0.005 | |
Coulouarn_TGF beta [28] | 8.25 | 1.90–35.91 | 0.005 | |
Tumour grade (poorly differentiated) | Hoshida_S1 [12] | 4.50 | 1.04–19.39 | 0.044 |
Yamashita_EpCAM [48] | 4.50 | 1.04–19.39 | 0.044 | |
Boyault_G3 [25] | 4.71 | 1.18–18.86 | 0.028 | |
Lee_Poor survival [49] | 5.67 | 1.37–23.46 | 0.017 | |
Minguez_Vascular invasion [9] | 5.87 | 1.43–24.11 | 0.014 | |
Woo_Cholangiocarcinoma_like [26] | 5.87 | 1.43–24.11 | 0.014 | |
Andersen_KRT19 [27] | 9.90 | 2.18–44.98 | 0.003 | |
Coulouarn_TGF beta [28] | 9.90 | 2.18–44.98 | 0.003 | |
Hoshida_S1/S2 [12] | 10.20 | 2.26–46.09 | 0.003 | |
Chiang_Proliferation [22] | 10.56 | 2.17–51.42 | 0.004 | |
Villanueva_KRT19 [6] | 13.93 | 2.78–69.88 | 0.001 | |
Cairo_Hepatoblastoma [47] | 16.33 | 1.75–152.80 | 0.014 | |
Novak_Met [50] | 21.00 | 2.25–195.79 | 0.008 |